Drug application
MONOPRIL-HCT (FOSINOPRIL SODIUM, HYDROCHLOROTHIAZIDE)
Drugs@FDA NDA 020286 · BRISTOL MYERS SQUIBB
Key facts
| Drug name | MONOPRIL-HCT |
|---|---|
| Active ingredients | FOSINOPRIL SODIUM, HYDROCHLOROTHIAZIDE |
| Application type | NDA |
| Application number | 020286 |
| Company | BRISTOL MYERS SQUIBB |
| Dosage forms | TABLET, ORAL |
| Strength | 20MG;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Nov 30, 1994 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: